Page last updated: 2024-09-03

n,n-dimethylarginine and Cardiomyopathy, Dilated

n,n-dimethylarginine has been researched along with Cardiomyopathy, Dilated in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Burger, AL; Demyanets, S; Diedrich, A; Pezawas, T; Stojkovic, S; Wojta, J1
Anderssohn, M; Böger, RH; Frey, N; Lüneburg, N; Lutz, M; Rosenberg, M; Schwedhelm, E; Zugck, C1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Cardiomyopathy, Dilated

ArticleYear
Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - A prospective, controlled long-term study.
    Clinical biochemistry, 2020, Volume: 83

    Topics: Aged; Arginine; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left

2020
The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Journal of cardiac failure, 2012, Volume: 18, Issue:12

    Topics: Arginine; Biomarkers; Cardiomyopathies; Cardiomyopathy, Dilated; Chromatography, Liquid; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Severity of Illness Index; Tandem Mass Spectrometry

2012